We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+0.31%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$81.2B
AUM Growth
+$1.02B
Cap. Flow
+$958M
Cap. Flow %
1.18%
Top 10 Hldgs %
10.24%
Holding
4,189
New
550
Increased
1,503
Reduced
1,391
Closed
422

Sector Composition

Rank Sector Weight
1 Technology 15.15%
2 Consumer Discretionary 12.74%
3 Healthcare 11.89%
4 Financials 8.05%
5 Industrials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEOS
3701
DELISTED
Neos Therapeutics, Inc
NEOS
$28K ﹤0.01%
18,653
-25,253
-58% -$40.9K
ICD
3702
DELISTED
Independence Contract Drilling, Inc.
ICD
$27K ﹤0.01%
1,128
-15,817
-93% -$408K
VATE icon
3703
INNOVATE Corp
VATE
$102M
$26K ﹤0.01%
1,091
-199
-15% -$4.32K
NCSM icon
3704
NCS Multistage Holdings
NCSM
$127M
$25K ﹤0.01%
+620
New +$31.5K
TNK icon
3705
Teekay Tankers
TNK
$3.19B
$24K ﹤0.01%
2,324
VIVS
3706
VivoSim Labs
VIVS
$3.91M
$24K ﹤0.01%
389
-83
-18% -$6.99K
TLGT
3707
DELISTED
Teligent, Inc
TLGT
$22K ﹤0.01%
2,284
-520
-19% -$4.1K
CTIC
3708
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$18K ﹤0.01%
21,396
+10,094
+89% +$7.71K
TRVN
3709
DELISTED
Trevena, Inc.
TRVN
$15K ﹤0.01%
25
-36
-59% -$21.1K
HOS
3710
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$14K ﹤0.01%
18,734
ADXS
3711
DELISTED
Advaxis Inc
ADXS
$13K ﹤0.01%
48,957
+19,357
+65% +$13.2K
VRDN icon
3712
Viridian Therapeutics
VRDN
$2.72B
$12K ﹤0.01%
1,127
-1,769
-61% -$39.1K
TALO.WS
3713
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$12K ﹤0.01%
12,800
BLCM
3714
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$11K ﹤0.01%
+1,087
New +$14.2K
LCTX icon
3715
Lineage Cell Therapeutics
LCTX
$276M
$10K ﹤0.01%
+10,354
New +$10.7K
AREX
3716
DELISTED
Approach Resources Inc.
AREX
$2K ﹤0.01%
11,329
ABCB icon
3717
Ameris Bancorp
ABCB
$5.77B
-10,252
Closed -$386K
ABEV icon
3718
Ambev
ABEV
$45B
-1,171,494
Closed -$5.47M
ABUS icon
3719
Arbutus Biopharma
ABUS
$1.03B
-19,300
Closed -$40K
AEO icon
3720
American Eagle Outfitters
AEO
$2.83B
-183,818
Closed -$3.11M
AER icon
3721
AerCap
AER
$23.2B
-8,860
Closed -$468K
AFL icon
3722
Aflac
AFL
$59.3B
-75,797
Closed -$4M
AIFA
3723
All In FutureTech Alliance Inc
AIFA
$20.2M
-40,000
Closed -$2.46M
AHT
3724
Ashford Hospitality Trust
AHT
$21.5M
-15
Closed -$45K
AIN icon
3725
Albany International
AIN
$1.66B
-14,939
Closed -$1.24M

Similar funds

David Shaw's Q3 2019 Portfolio in Review

As of Q3 2019, David Shaw held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

David Shaw's Q3 2019 filing shows 550 new, 1,503 increased, 1,391 reduced and 422 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M. The largest sale was Anadarko Petroleum, an estimated $567M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
  • David Shaw added most to PayPal in Q3 2019, an estimated $354M increase.
  • David Shaw's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
  • David Shaw fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
  • David Shaw's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
  • David Shaw opened 550 new positions and closed 422 in Q3 2019.
  • David Shaw's portfolio value rose 1.3% quarter-over-quarter to $81.2B.

Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.